Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
Titel:
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
Auteur:
Calabresi, Peter A Kieseier, Bernd C Arnold, Douglas L Balcer, Laura J Boyko, Alexey Pelletier, Jean Liu, Shifang Zhu, Ying Seddighzadeh, Ali Hung, Serena Deykin, Aaron